Find patient medical information for Clobetasol topical on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings ...

Clobetasol propionate is a generic drug that’s prescribed for inflammation, itching, and plaque psoriasis. The medication is available as several brand-name drugs, including Clobex and Impelko ...

Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Clobetasol Propionate Ointment USP, 0.05%, 60 g Tubes, Lot AC13786 Due to Microbial Contamination. Dec. 26, 2021.

The recalled lot of Clobetasol Propionate Ointment USP, 0.05%, 60g tubes; NDC # 51672-1259-3; Lot # AC13786; expiration date December 2022, was distributed to 2 wholesale distributors between ...

NEW YORK, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic technology company, today announced the U.S. launch and commercial availability of clobetasol propionate ...

Clobetasol propionate ophthalmic suspension 0.05% was approved to treat inflammation and pain after ocular surgery. Eyenovia plans to launch the eye drop in the U.S. later this year.

Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals. Business Wire . Mon, Jun 9, 2025, 4:00 AM 7 min read.

The Food and Drug Administration (FDA) has approved Clobetasol Propionate Ophthalmic Suspension 0.05% for the treatment of postoperative inflammation and pain following ocular surgery.

Eyenovia Congratulates Formosa Pharmaceuticals on FDA Approval of Clobetasol Propionate Ophthalmic Suspension 0.05% for the Treatment of Post-operative Inflammation and Pain Following Ocular Surgery.

Clobetasol propionate ophthalmic suspension, 0.05% (APP13007) was approved by the Food and Drug Administration in 2024. APP13007's active ingredient is the superpotent corticosteroid, ...

Clobetasol propionate is a potent steroid that was approved in the U.S. by the FDA on March 4, 2024, for the reduction of inflammation and pain associated with the estimated seven million ocular ...